Your browser doesn't support javascript.
loading
Efficacy and safety of nucleoside-sparing regimen based on raltegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.
Jablonowska, Elzbieta; Pulik, Piotr; Kalinowska, Anna; Gasiorowski, Jacek; Parczewski, Milosz; Bociaga-Jasik, Monika; Pulik, Lukasz; Siwak, Ewa; Wójcik, Kamila.
Afiliación
  • Jablonowska E; Clinic of Infectious Diseases and Hepatology, Medical University of Lodz, Lodz, Poland.
  • Pulik P; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland.
  • Kalinowska A; Department of Infectious Diseases, Jagiellonian University Medical College, Krakow, Poland.
  • Gasiorowski J; Department of Infectious Diseases, Hepatology and Acquired Immune Deficiencies, Wroclaw Medical University, Wroclaw, Poland.
  • Parczewski M; Department of Infectious and Tropical Diseases and Immune Deficiency, Pomeranian Medical University, Szczecin, Poland.
  • Bociaga-Jasik M; Department of Infectious Diseases, Jagiellonian University Medical College, Krakow, Poland.
  • Pulik L; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland.
  • Siwak E; Hospital for Infectious Diseases, HIV Out-Patient Clinic, Warsaw, Poland.
  • Wójcik K; Clinic of Infectious Diseases and Hepatology, Medical University of Lodz, Lodz, Poland.
J Med Virol ; 89(12): 2122-2129, 2017 12.
Article en En | MEDLINE | ID: mdl-28390164
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Inhibidores de la Proteasa del VIH / Fármacos Anti-VIH / Darunavir / Raltegravir Potásico Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Año: 2017 Tipo del documento: Article País de afiliación: Polonia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / Inhibidores de la Proteasa del VIH / Fármacos Anti-VIH / Darunavir / Raltegravir Potásico Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Med Virol Año: 2017 Tipo del documento: Article País de afiliación: Polonia